Safety and Efficacy Study of Oral Senicapoc on Allergen Challenge in Atopic Asthmatic Subjects

Status:
Completed

Trial end date:
2009-05-01

Target enrollment:

Participant gender:

The purpose of the study is to determine whether senicapoc can decrease changes in FEV1 following allergen challenge in atopic allergic subjects.

Phase 2

Icagen